Loading…
National HealthCare Corporation is projected to rise to $273.93 by 2027, a +28% move from its current price of $214.18. NHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $210.97 | $214.32 | $217.73 | +0.07% |
| Jul 13 | $209.73 | $214.46 | $219.30 | +0.13% |
| Jul 14 | $208.82 | $214.61 | $220.55 | +0.20% |
| Jul 15 | $208.08 | $214.75 | $221.63 | +0.27% |
| Jul 16 | $207.44 | $214.89 | $222.61 | +0.33% |
| Jul 17 | $206.88 | $215.04 | $223.51 | +0.40% |
| Jul 18 | $206.38 | $215.18 | $224.35 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $206.38 | $215.18 | $224.35 | +0.47% |
| Week 2 | $203.79 | $216.18 | $229.33 | +0.93% |
| Week 3 | $202.04 | $217.19 | $233.48 | +1.41% |
| Week 4 | $200.73 | $218.20 | $237.20 | +1.88% |
| Week 5 | $199.68 | $219.22 | $240.67 | +2.35% |
| Week 6 | $198.84 | $220.24 | $243.95 | +2.83% |
| Week 7 | $198.13 | $221.27 | $247.11 | +3.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services.
Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. It provides memory care units and sub-acute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living. Its independent living facilities offer specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders.
In addition, the company homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, the company offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.
National HealthCare Corporation (NHC) trades at $218.44 per share with a market cap of $3.41B, and is ranked 1622. The near-term technical picture shows a 30-day range from $195.50 to $244.08.
In 2026, the forecast lists a min of $128.69, an avg of $218.44, and a max of $309.10 with sentiment Neutral, representing an ROI of 0. From 2027 onward, the forecast turns bullish, with 2027 avg $289.29 and max $369.56 (ROI 32.4) and 2030 avg $435.51 and max $593.89 (ROI 99.4). By 2040, the forecast shows avg $1,605.58 and max $2,449.59 (ROI 635); by 2050, avg $3,326.48 and max $5,439.84 (ROI 1422.8).
A major floor 27.2% below — a decisive break under it would weaken the trend.
The nearest floor, 16.2% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 12.9% above — clearing it would confirm fresh momentum.
Key NHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $214.03 | Buy | $212.67 | Buy |
| MA 10 | $212.55 | Buy | $211.08 | Buy |
| MA 20 | $205.23 | Buy | $206.22 | Buy |
| MA 50 | $193.94 | Buy | $194.93 | Buy |
| MA 100 | $179.01 | Buy | $181.17 | Buy |
| MA 200 | $156.28 | Buy | $162.16 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.06 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 46.86 | Neutral |
| Williams %R (14) | -42.65 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 5.43 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 57.35 | Neutral |
| TRIX (15) | 0.47 | Buy |
| Awesome (5,34) | 15.54 | Buy |
| Ultimate (7,14,28) | 54.18 | Neutral |
| Momentum (10) | 8.85 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 213.04 | Buy |
| ADX (14) | 26.29 | Buy |
| ATR (14) | 3.05 | Info |
The 30-day technical picture is bullish, with RSI14 at 70, and moving averages suggesting upside: SMA50 is $189.90 and SMA200 is $153.87. Support is at $179.40 and resistance at $218.44.
The 30-day range spans from $195.50 to $244.08.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $128.69 | $214.18 | $296.49 | 0% | Neutral | |
| $224.34 | $273.93 | $349.71 | +28% | Bullish | |
| $239.89 | $298.42 | $391.27 | +39% | Bullish | |
| $275.79 | $348.37 | $466.49 | +63% | Bullish | |
| $298.62 | $382.29 | $521.13 | +78% | Bullish | |
| $348.79 | $451.99 | $625.87 | +111% | Bullish | |
| $422.81 | $554.08 | $778.16 | +159% | Bullish | |
| $468.23 | $620.07 | $882.11 | +190% | Bullish | |
| $522.62 | $698.98 | $1,006.24 | +226% | Bullish | |
| $553.38 | $747.13 | $1,087.53 | +249% | Bullish | |
| $877.59 | $1,235.80 | $1,885.07 | +477% | Bullish | |
| $1,626.41 | $2,456.29 | $4,016.28 | +10.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $128.69 | $214.18 | $252.95 | +0.00% |
| August 2026 | $187.80 | $219.86 | $262.98 | +2.65% |
| September 2026 | $193.46 | $227.56 | $274.31 | +3.51% |
| October 2026 | $194.04 | $229.18 | $278.08 | +0.71% |
| November 2026 | $195.98 | $232.28 | $283.38 | +1.35% |
| December 2026 | $203.35 | $241.79 | $296.49 | +4.10% |
Click any year to see its month-by-month NHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NHC is projected to trade between $128.69 and $296.49, averaging $214.18 — a potential gain of 0% from today's $214.18. Price action looks broadly range-bound.
National HealthCare Corporation's 2027 outlook centres on $273.93, within a $224.34 to $349.71 range. That is up +28% on the projected 2026 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, NHC could reach as high as $391.27, with a base case around $298.42 and support toward $239.89 — roughly +39% from $214.18. Momentum favours further upside here.
Expect NHC to range from $275.79 to $466.49 through 2029. The $348.37 average target implies a +63% move from current prices. That is up +17% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NHC price prediction for 2030 points to an average of $382.29 (low $298.62, high $521.13) — a potential gain of +78% on today's $214.18. Momentum favours further upside here.
In 2031, NHC is projected to trade between $348.79 and $625.87, averaging $451.99 — a potential gain of +111% from today's $214.18. That is up +18% on the projected 2030 average. Buyers look set to stay in control over this stretch.
National HealthCare Corporation's 2032 outlook centres on $554.08, within a $422.81 to $778.16 range. That is up +23% on the projected 2031 average. That marks a +159% change versus current levels. Momentum favours further upside here.
By 2033, NHC could reach as high as $882.11, with a base case around $620.07 and support toward $468.23 — roughly +190% from $214.18. Buyers look set to stay in control over this stretch.
Expect NHC to range from $522.62 to $1,006.24 through 2034. The $698.98 average target implies a +226% move from current prices. That is up +13% on the projected 2033 average. Momentum favours further upside here.
The NHC price prediction for 2035 points to an average of $747.13 (low $553.38, high $1,087.53) — a potential gain of +249% on today's $214.18. Buyers look set to stay in control over this stretch.
In 2040, NHC is projected to trade between $877.59 and $1,885.07, averaging $1,235.80 — a potential gain of +477% from today's $214.18. That is up +65% on the projected 2035 average. Momentum favours further upside here.
National HealthCare Corporation's 2050 outlook centres on $2,456.29, within a $1,626.41 to $4,016.28 range. That is up +99% on the projected 2040 average. That marks a +10.5x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NHC today (≈ 4.66897 NHC) could be worth
$11,468.33
+$10,468.33 (+1047%) by 2050 · US Dollar
Based on the average projected NHC price of $2,456.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NHCwould be worth at today's price.
$1,000 invested in NHC on Jul 10, 2025 (≈ 9.612612 NHC) would be worth
$2,058.83
+$1,058.83 (+105.9%) today · 2.06× · US Dollar
Based on a NHC entry price of $104.03 vs. today's $214.18.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $218.44 | $980.5 | -2.0% |
| 1 month ago | $191.81 | $1,116.63 | +11.7% |
| 3 months ago | $170.85 | $1,253.61 | +25.4% |
| 6 months ago | $133.91 | $1,599.43 | +59.9% |
| 1 year ago | $104.03 | $2,058.83 | +105.9% |
| All time (5.0y) ago | $72.09 | $2,971.01 | +197.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NHC forecast.
Our base-case forecast reaches $430.00 around 2031.
Implied market cap at $430.00: $6.72B
The multi-year forecast shows a bullish trajectory after a neutral start in 2026. For 2026, the avg price is $218.44 with a min of $128.69 and a max of $309.10 (ROI 0). In 2027 the avg climbs to $289.29 and the max to $369.56 (ROI 32.4), and by 2030 the avg reaches $435.51 with a max of $593.89 (ROI 99.4).
The trend continues with 2031 at $531.93, 2032 at $665.13, 2033 at $742.78, 2034 at $853.69, and 2035 at $924.13, all with bullish sentiment. By 2040 the avg is $1,605.58 and the max $2,449.59 (ROI 635), and by 2050 the avg is $3,326.48 and the max $5,439.84 (ROI 1422.8). These are estimates and not guarantees, and actual results will depend on future market conditions and other factors.
Tap a question to reveal the answer.
Avg $435.51, min $340.09, max $593.89, ROI 99.4, sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with 2030 avg $435.51 and ROI 99.4; 2040 avg $1,605.58 (ROI 635) and 2050 avg $3,326.48 (ROI 1422.8). 2026 is Neutral with avg $218.44 and ROI 0.
Yes. The forecast max price reaches $524.07 in 2029 and $593.89 in 2030.
Current price $218.44; market cap $3.41B.
RSI14 70; SMA50 $189.90; SMA200 $153.87; support $179.40; resistance $218.44; 30-day range low $195.50, high $244.08.
National HealthCare Corporation Community Discussion
0Share your National HealthCare Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.